CD9 and cancer: Materials and methods: A novel protein array based on biotin-labelled anti-tetraspanin (CD9, CD63 and CD81) antibodies specific for exosomes in general enabled capture of exosomes from crude human donor plasma and MV preparations from stable isotope-labelled cancer cells and synovial fluid.